Updated Oct 02, 2018

CSense: Rapid, simple and low cost strip for early screening of Cervical Cancer at the Point of care

The innovation has no owner

CLAIM IT

Snapshot

Focus Areas:

Infectious & Vector Diseases and Sexual and Reproductive Health

Infectious & Vector Diseases and Sexual and Reproductive HealthSEE LESS

Implemented In:

India

IndiaSEE LESS

1
Country Implemented In
Verified Funding
?

Innovation Description

Cervical cancer is the 2nd largest cause of cancer deaths in women around the world. Globally 288000 women die of cervical cancer.In India 74000 females succumb, which is 1/3rd of the global burden. Most of these deaths are preventable. While methods like Pap and HPV DNA test are employed for cervical screening, they need a lab, trained manpower and suffer with many drawbacks. Thus there is a critical need for a rapid, accurate and low cost diagnostic test that can be used at the point of care.

Milestones

Jun 2018
Funds RaisedVERIFIED
$74,432
Date Unknown
New Country
India
Date Unknown
New Country
India